Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.58 CAD
Change Today 0.00 / 0.00%
Volume 0.0
As of 3:59 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

biorem inc (BRM) Snapshot

Open
C$0.45
Previous Close
C$0.58
Day High
C$0.60
Day Low
C$0.43
52 Week High
08/31/15 - C$0.60
52 Week Low
01/13/15 - C$0.10
Market Cap
7.9M
Average Volume 10 Days
57.1K
EPS TTM
C$0.01
Shares Outstanding
13.6M
EX-Date
--
P/E TM
43.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOREM INC (BRM)

Related News

No related news articles were found.

biorem inc (BRM) Related Businessweek News

No Related Businessweek News Found

biorem inc (BRM) Details

Biorem Inc., an environmental biotechnology company, designs, manufactures, and sells air pollution control systems that are used to eliminate odorous and harmful contaminants in Canada, the United States, China, and internationally. The company offers biofilters for the removal of odors, hydrogen sulfide (H2S), volatile organic compounds, and hazardous air pollutants, as well as for the conditioning of biogas renewable energy; and biotrickling filters for applications of high concentrations of H2S or other water soluble compounds. It also provides multi-stage systems to treat odors associated with various municipal wastewater treatment processes; and biogas conditioning systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company is headquartered in Guelph, Canada.

biorem inc (BRM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$147.5K
Chief Financial Officer and Secretary
Total Annual Compensation: C$97.3K
Vice President of Research & Development
Total Annual Compensation: C$162.3K
Compensation as of Fiscal Year 2014.

biorem inc (BRM) Key Developments

BIOREM Inc. Announces Earnings Results for the Second Quarter and Six Month Ended June 30, 2015

BIOREM Inc. announced earnings results for the second quarter and six month ended June 30, 2015. For the quarter, the company reported revenue of CAD 4709,000 against CAD 2,459,000 a year ago. EBITDA was CAD 862,000 against LBITDA of CAD 623,000 a year ago. Net earnings were CAD 718,000 against net loss of CAD 835,000 a year ago. Diluted earnings per share were CAD 0.02 against diluted loss per share of CAD 0.06 a year ago. The revenue increase came from each of the geographic markets in which Biorem operates. For the six months, the company reported revenue of CAD 9,398,000 against CAD 4,433,000 a year ago. EBITDA was CAD 1,605,000 against LBITDA of CAD 965,000 a year ago. Net earnings were CAD 1,247,000 against net loss of CAD 1,366,000 a year ago. Diluted earnings per share were as CAD 0.04 against diluted loss per share of CAD 0.11 a year ago.

BIOREM Inc. Announces Election of Directors

At the annual meeting of shareholders of BIOREM Inc. held on June 24, 2015 Brian Herner, Robert Nally, Bernardo Llovera and Derek Webb were elected directors of the company and will hold office until the next annual general shareholders meeting.

BIOREM Inc. Reports Earnings Results for the First Quarter Ended March 31, 2015

BIOREM Inc. reported earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenues totaled CAD 4.7 million, an 18 % increase over the previous quarter, and CAD 2.7 million or a 138% increase from revenues of CAD 1.9 million recorded during the first quarter of 2014. The increase in 2015 first quarter Revenue was a result of the substantially higher order backlog at December 31, 2014. EBITDA was CAD 0.720 million against LBITDA of CAD 0.318 million a year ago. Net earnings were CAD 0.528 million or CAD 0.02 per diluted share against net loss of CAD 0.531 million or CAD 0.04 per diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRM:CN C$0.58 CAD 0.00

BRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BRM.
View Industry Companies
 

Industry Analysis

BRM

Industry Average

Valuation BRM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 12.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOREM INC, please visit www.biorem.biz. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.